Medium impact
Reminders on pain management and opioid antagonists
Harvard Pilgrim Health Care·Identified Jul 9, 2026
HCPCS J0574 is officially defined as "Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine." HCPCS J0574 is referenced in 1 tracked payer policy change from Harvard Pilgrim Health Care. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J0574 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.